Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11974971 | Compositions and methods for treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2024-05-07 |
| 11865113 | Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH) | J. Gordon Foulkes, Kieran George Mooney, Charles Rodney Greenaway Evans, Keith Johnson, Howard Welgus +1 more | 2024-01-09 |
| 11759441 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2023-09-19 |
| 11065215 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2021-07-20 |
| 10668031 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2020-06-02 |
| 10610500 | Chemosensory receptor ligand-based therapies | Alain D. Baron, Mark S. Fineman | 2020-04-07 |
| 10603291 | Compositions and methods for treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2020-03-31 |
| 10201511 | Compositions and methods for treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2019-02-12 |
| 10159658 | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | Alain D. Baron, Mark S. Fineman | 2018-12-25 |
| 10154972 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2018-12-18 |
| 10028923 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2018-07-24 |
| 9962344 | Chemosensory receptor ligand-based therapies | Alain D. Baron, Mark S. Fineman | 2018-05-08 |
| 9770422 | Compositions and methods for treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2017-09-26 |
| 9572784 | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | Alain D. Baron, Mark S. Fineman | 2017-02-21 |
| 9480663 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2016-11-01 |
| 9481642 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2016-11-01 |
| 9463170 | Chemosensory receptor ligand-based therapies | Alain D. Baron, Mark S. Fineman | 2016-10-11 |
| 9211263 | Compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2015-12-15 |
| 9050292 | Chemosensory receptor ligand-based therapies | Alain D. Baron, Martin R. Brown, Christopher R. G. Jones, Mark S. Fineman | 2015-06-09 |
| 8796338 | Biguanide compositions and methods of treating metabolic disorders | Alain D. Baron, Mark S. Fineman | 2014-08-05 |
| 8759291 | Methods of treatment using exendin peptides or GLP-1 peptides | Andrew A. Young, Will Vine, Kathryn S. Prickett | 2014-06-24 |
| 7928065 | Methods of treatment using exendin peptides or GLP-1 peptides | Andrew A. Young, Will Vine, Kathryn S. Prickett | 2011-04-19 |
| 7442680 | Inotropic and diuretic effects of GLP-1 and GLP-1 agonists | Andrew A. Young, Will Vine, Kathryn S. Prickett | 2008-10-28 |
| 6703359 | Inotropic and diuretic effects of exendin and GLP-1 | Andrew A. Young, Will Vine, Kathryn S. Prickett | 2004-03-09 |